Healthcare - Biotechnology - NASDAQ - US
$ 170.74
-3.75 %
$ 4.91 B
Market Cap
96.46
P/E
INCOME STATEMENT
50.7 M
REVENUE
-110 M
OPERATING INCOME
10.9 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Krystal Biotech, Inc.
| Revenue | 50.7 M |
| Cost Of Revenue | 3.09 M |
| Gross Profit | 47.6 M |
| Operating Expenses | 160 M |
| Operating Income | -110 M |
| Other Expenses | -121 M |
| Net Income | 10.9 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 50.7 | 0 | 0 | 0 | 0 | 1.0 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 3.1 | 4.1 | 2.8 | 1.9 | 1.0 | 0.1 | 23 K | 2 K |
| Gross Profit | 47.6 | (4.1) | (2.8) | (1.9) | (1.0) | 0.9 | 23 K | 2 K |
| OPERATING INCOME | ||||||||
| Operating Expenses | 160.4 | 120.2 | 68.3 | 33.0 | 22.1 | 11.9 | 4.8 | 1.1 |
| Selling, General and Administrative Expenses | 98.4 | 77.7 | 40.4 | 15.1 | 6.5 | 4.2 | 1.6 | 0.4 |
| Research and Development Expenses | 46.4 | 42.5 | 27.9 | 17.9 | 15.6 | 7.8 | 3.2 | 0.7 |
| Operating Income | (109.7) | (145.2) | (68.3) | (33.0) | (22.1) | (11.9) | (4.8) | (1.1) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 0 | 5.2 | 1.5 | 0 | 0 | 1.0 | 3.1 | 7 K |
| Total Other Income | 122.6 | 5.2 | (1.3) | 0.8 | 3.0 | 1.0 | (3.1) | 7 K |
| Pre-Tax Income | 12.9 | (140.0) | (69.6) | (32.2) | (19.1) | (10.9) | (7.9) | (1.1) |
| NET INCOME | ||||||||
| Tax Provision | 2.0 | 34.0 | 2.7 | 1.6 | 0.6 | 20.1 K | 0 | 0 |
| Net Income | 10.9 | (140.0) | (69.6) | (32.2) | (19.1) | (10.9) | (7.9) | (1.1) |
| EPS | 0.4 | 5.49 | 3.13 | 1.71 | 1.2 | 0.97 | 1.48 | 0.27 |